MedPath

Recognizing patients with (a higher risk of) endometrial cancer; the rol of fat distribution and inflammation in the origin of endometrial cancer, a study that focuses on prevention and predictio

Recruiting
Conditions
cancer of the womb
Uterine cancer
10038594
Registration Number
NL-OMON52042
Lead Sponsor
Medisch Universitair Ziekenhuis Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
160
Inclusion Criteria

Cases: Subjects with endometrial cancer/hyperplasia with atypia, who are
planned for hysterectomy with bilateral salpingo-oophorectomy.
Controls: Subjects who are planned for bilateral salpingo-oophorectomy without
malignancy and are older than 40

Exclusion Criteria

Malignancy 5 years prior to inclusion (basal cell carcinoma excluded)
Use of systemic hormonale therapy the past 12 months
inadequate knowledge of the Dutch language
Contra-indication for ct-scan

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Hormone levels and inflammation markers after BSO depending on BMI</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Effect of fat distribution on hormone levels and inflammation markers<br /><br>Effect of BSO on subjects complaints (depending on BMI)</p><br>
© Copyright 2025. All Rights Reserved by MedPath